A detailed history of Private Trust CO Na transactions in Repligen Corp stock. As of the latest transaction made, Private Trust CO Na holds 76 shares of RGEN stock, worth $10,556. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76
Previous 68 11.76%
Holding current value
$10,556
Previous $8,000 37.5%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$119.79 - $167.35 $958 - $1,338
8 Added 11.76%
76 $11,000
Q2 2024

Jul 23, 2024

SELL
$120.0 - $182.95 $1,080 - $1,646
-9 Reduced 11.69%
68 $8,000
Q4 2023

Jan 24, 2024

BUY
$114.17 - $185.35 $342 - $556
3 Added 4.05%
77 $13,000
Q2 2023

Jul 28, 2023

BUY
$138.42 - $180.31 $2,353 - $3,065
17 Added 29.82%
74 $10,000
Q1 2023

Apr 12, 2023

BUY
$154.26 - $198.1 $771 - $990
5 Added 9.62%
57 $9,000
Q2 2022

Sep 16, 2022

BUY
$140.68 - $188.02 $7,315 - $9,777
52 New
52 $8,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.